Semaglutide, used for diabetes and obesity, may reduce alcohol cravings in adults with alcohol use disorder, offering a potential solution to a major treatment gap.

Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...

Gold nanoparticles help lose fat more effectively than a common weight-loss drug, improving body fat levels and organ health ...

Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...